Sam Fazeli
Sam Fazeli has discussed 6 US public companies across 13 Bloomberg Intelligence episodes, per Ticker.id. Top: $MRK, $AZN, $MRNA, $PFE, $BNTX.
This has already failed. A monitoring committee that looks at trials on an ongoing basis said, you know, there's no safety issues here, but we don't think you're going to be able to make it on efficacy.
Sam Fazeli · Bloomberg News Now · Stocks Close Lower, Fed Chair Vows To Bring Inflation to 2%, More · 2026-08-28This has already failed. This failed back in October 2025 in terms of not— the monitoring committee that looks at trials on an ongoing basis said, you know, there's no safety issues here, but we don't think you're going to be able to make it an vaccine.
Sam Fazeli · Bloomberg News Now · Warsh: Inflation Not Slowing, Trump Can't Move Hush Money Case, More · 2026-08-28This has already failed. This failed back in October 2025 in terms of not— the monitoring committee that looks at trials on an ongoing basis said, you know, there's no safety issues here, but we don't think you're going to be able to make it on efficacy.
Sam Fazeli · Bloomberg News Now · Warsh Vows to Reach 2% Target, Two-Year Yields Jump, More · 2026-08-28
- $MRK Merck — 5 mentions
- $AZN AstraZeneca — 4 mentions
- $MRNA Moderna — 3 mentions
- $PFE Pfizer — 2 mentions
- $BNTX BioNTech — 1 mention
- $BMY Bristol Myers — 1 mention
- Bloomberg Intelligence · Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker · 2026-07-16